SHMT2 is highly upregulated in diverse cancer types, correlated with poor outcomes, and may support tumor aggressiveness by enhancing mitochondrial functions, including redox balance and nucleotide synthesis27,29,37. This evidence concerns the gene SHMT2 and neoplasm.